View Future GrowthNeochim AD 過去の業績過去 基準チェック /46Neochim ADの収益は年間平均-42%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間2.8% 3.9%割合で 減少しています。 Neochim ADの自己資本利益率は13.4%であり、純利益率は5.6%です。主要情報-42.05%収益成長率-42.12%EPS成長率Chemicals 業界の成長13.08%収益成長率-3.86%株主資本利益率13.38%ネット・マージン5.55%前回の決算情報31 Mar 2026最近の業績更新分析記事 • Jun 05Neochim AD's (BUL:NEOH) Strong Earnings Are Of Good QualityEven though Neochim AD's ( BUL:NEOH ) recent earnings release was robust, the market didn't seem to notice. Our...Reported Earnings • Jun 02First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: €81.5m (up 73% from 1Q 2025). Net income: €10.8m (up €11.7m from 1Q 2025). Profit margin: 13% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 03Full year 2025 earnings released: EPS: лв0.31 (vs лв1.50 loss in FY 2024)Full year 2025 results: EPS: лв0.31 (up from лв1.50 loss in FY 2024). Revenue: лв355.2m (up 31% from FY 2024). Net income: лв813.0k (up лв4.68m from FY 2024). Profit margin: 0.2% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year whereas the company’s share price has fallen by 21% per year.Reported Earnings • Aug 30Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: лв77.8m (up 100% from 2Q 2023). Net income: лв8.51m (up лв22.3m from 2Q 2023). Profit margin: 11% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.Reported Earnings • Jun 04First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: лв55.8m (down 48% from 1Q 2023). Net loss: лв5.77m (loss narrowed 41% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 03Full year 2023 earnings released: лв15.12 loss per share (vs лв27.09 profit in FY 2022)Full year 2023 results: лв15.12 loss per share (down from лв27.09 profit in FY 2022). Revenue: лв294.5m (down 53% from FY 2022). Net loss: лв39.1m (down 156% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.すべての更新を表示Recent updatesNew Risk • Jul 03New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 12% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.8% average weekly change). Earnings have declined by 42% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€44.0m market cap, or US$50.2m).New Risk • Jun 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bulgarian stocks, typically moving 7.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.7% average weekly change). Earnings have declined by 42% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€44.0m market cap, or US$50.2m).Upcoming Dividend • Jun 25Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 29 June 2026. Payment date: 11 August 2026. The company last paid an ordinary dividend in July 2021. The average dividend yield among industry peers is 3.2%.分析記事 • Jun 05Neochim AD's (BUL:NEOH) Strong Earnings Are Of Good QualityEven though Neochim AD's ( BUL:NEOH ) recent earnings release was robust, the market didn't seem to notice. Our...Reported Earnings • Jun 02First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: €81.5m (up 73% from 1Q 2025). Net income: €10.8m (up €11.7m from 1Q 2025). Profit margin: 13% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bulgarian stocks, typically moving 9.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 44% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.9% average weekly change). Market cap is less than US$100m (€40.6m market cap, or US$46.9m).分析記事 • Feb 12Returns On Capital Signal Tricky Times Ahead For Neochim AD (BUL:NEOH)Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €12.50, the stock trades at a trailing P/E ratio of 78.8x. Average trailing P/E is 19x in the Chemicals industry in Europe. Total loss to shareholders of 30% over the past three years.Reported Earnings • Feb 03Full year 2025 earnings released: EPS: лв0.31 (vs лв1.50 loss in FY 2024)Full year 2025 results: EPS: лв0.31 (up from лв1.50 loss in FY 2024). Revenue: лв355.2m (up 31% from FY 2024). Net income: лв813.0k (up лв4.68m from FY 2024). Profit margin: 0.2% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year whereas the company’s share price has fallen by 21% per year.分析記事 • Nov 29Why Investors Shouldn't Be Surprised By Neochim AD's (BUL:NEOH) Low P/SYou may think that with a price-to-sales (or "P/S") ratio of 0.2x Neochim AD ( BUL:NEOH ) is a stock worth checking...分析記事 • Oct 19Improved Revenues Required Before Neochim AD (BUL:NEOH) Stock's 35% Jump Looks JustifiedNeochim AD ( BUL:NEOH ) shareholders have had their patience rewarded with a 35% share price jump in the last month...Reported Earnings • Aug 30Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: лв77.8m (up 100% from 2Q 2023). Net income: лв8.51m (up лв22.3m from 2Q 2023). Profit margin: 11% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.分析記事 • Jul 30Benign Growth For Neochim AD (BUL:NEOH) Underpins Its Share PriceNeochim AD's ( BUL:NEOH ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing investment...Reported Earnings • Jun 04First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: лв55.8m (down 48% from 1Q 2023). Net loss: лв5.77m (loss narrowed 41% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.New Risk • Apr 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bulgarian stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Market cap is less than US$100m (лв47.8m market cap, or US$26.2m).Reported Earnings • Mar 03Full year 2023 earnings released: лв15.12 loss per share (vs лв27.09 profit in FY 2022)Full year 2023 results: лв15.12 loss per share (down from лв27.09 profit in FY 2022). Revenue: лв294.5m (down 53% from FY 2022). Net loss: лв39.1m (down 156% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.分析記事 • Jan 23Market Still Lacking Some Conviction On Neochim AD (BUL:NEOH)Neochim AD's ( BUL:NEOH ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing investment...New Risk • Jan 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bulgarian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (7.5% average weekly change). Market cap is less than US$100m (лв73.2m market cap, or US$40.8m).Reported Earnings • Nov 30Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: лв75.1m (down 19% from 3Q 2022). Net loss: лв201.0k (down 143% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 31Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: лв39.3m (down 70% from 2Q 2022). Net loss: лв13.8m (down 223% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.New Risk • Jul 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bulgarian stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (6.0% average weekly change). Market cap is less than US$100m (лв81.5m market cap, or US$45.2m).分析記事 • Jul 05Be Wary Of Neochim AD (BUL:NEOH) And Its Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...Upcoming Dividend • Jun 27Upcoming dividend of лв5.00 per share at 19% yieldEligible shareholders must have bought the stock before 04 July 2023. Payment date: 17 August 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 19%. Within top quartile of Bulgarian dividend payers (7.3%). Higher than average of industry peers (4.2%).Reported Earnings • Jun 02First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: лв108.9m (down 59% from 1Q 2022). Net loss: лв9.72m (down 115% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.お知らせ • May 31Neochim AD, Annual General Meeting, Jun 21, 2023Neochim AD, Annual General Meeting, Jun 21, 2023, at 12:00 E. Europe Standard Time.Reported Earnings • Mar 01Full year 2022 earnings released: EPS: лв30.70 (vs лв18.04 in FY 2021)Full year 2022 results: EPS: лв30.70 (up from лв18.04 in FY 2021). Revenue: лв646.0m (up 83% from FY 2021). Net income: лв79.4m (up 70% from FY 2021). Profit margin: 12% (in line with FY 2021). Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 30Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: лв105.7m (up 124% from 3Q 2021). Net income: лв464.0k (up лв6.22m from 3Q 2021). Profit margin: 0.4% (up from net loss in 3Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 122% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 1 highly experienced director. No independent directors (7 non-independent directors). Deputy Chairperson Elena Shopova was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Upcoming Dividend • Jun 27Upcoming dividend of лв5.00 per shareEligible shareholders must have bought the stock before 04 July 2022. Payment date: 17 August 2022. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 9.1%. Within top quartile of Bulgarian dividend payers (7.0%). Higher than average of industry peers (3.8%).Valuation Update With 7 Day Price Move • Apr 28Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to лв44.00, the stock trades at a trailing P/E ratio of 2.3x. Average trailing P/E is 14x in the Chemicals industry in Europe. Total returns to shareholders of 122% over the past three years.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Deputy Chairperson Elena Shopova was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improved over the past weekAfter last week's 28% share price gain to лв50.50, the stock trades at a trailing P/E ratio of 2.6x. Average trailing P/E is 14x in the Chemicals industry in Europe. Total returns to shareholders of 107% over the past three years.Valuation Update With 7 Day Price Move • Mar 14Investor sentiment improved over the past weekAfter last week's 18% share price gain to лв40.00, the stock trades at a trailing P/E ratio of 2.1x. Average trailing P/E is 14x in the Chemicals industry in Europe. Total returns to shareholders of 50% over the past three years.Reported Earnings • Mar 04Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: лв19.50 (up from лв5.61 in FY 2020). Revenue: лв354.0m (up 60% from FY 2020). Net income: лв50.4m (up 248% from FY 2020). Profit margin: 14% (up from 6.5% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to лв36.40, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 14x in the Chemicals industry in Europe. Total returns to shareholders of 28% over the past three years.分析記事 • Feb 22The Returns At Neochim AD (BUL:NEOH) Aren't GrowingThere are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Valuation Update With 7 Day Price Move • Jan 27Investor sentiment improved over the past weekAfter last week's 47% share price gain to лв33.00, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 16x in the Chemicals industry in Europe. Total returns to shareholders of 8.3% over the past three years.分析記事 • Jan 25Neochim AD (BUL:NEOH) Seems To Use Debt Rather SparinglyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...お知らせ • Jan 13Daniel Rumenov Gargov acquired a 5.12% stake in Neochim AD (BUL:NEOH) from Agrofer International Establishment.Daniel Rumenov Gargov acquired a 5.12% stake in Neochim AD (BUL:NEOH) from Agrofer International Establishment on January 12, 2022. Post completion, Agrofer International Establishment hold 2.56% stake of Neochim AD. Daniel Rumenov Gargov completed the acquisition of a 5.12% stake in Neochim AD (BUL:NEOH) from Agrofer International Establishment on January 12, 2022.Reported Earnings • Nov 30Third quarter 2021 earnings: Revenues in line with analyst expectationsThird quarter 2021 results: Revenue: лв48.5m (up 120% from 3Q 2020). Net loss: лв5.76m (loss narrowed 45% from 3Q 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.分析記事 • Nov 08Neochim AD's (BUL:NEOH) Shares Lagging The Market But So Is The BusinessWhen close to half the companies in Bulgaria have price-to-earnings ratios (or "P/E's") above 17x, you may consider...分析記事 • Oct 05Capital Allocation Trends At Neochim AD (BUL:NEOH) Aren't IdealIgnoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...Reported Earnings • Aug 29Second quarter 2021 earnings releasedThe company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: лв79.9m (up 40% from 2Q 2020). Net income: лв10.9m (down 48% from 2Q 2020). Profit margin: 14% (down from 37% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.分析記事 • Jun 07Neochim AD (BUL:NEOH) Has A Rock Solid Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Valuation Update With 7 Day Price Move • Apr 30Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to лв33.60, the stock trades at a trailing P/E ratio of 6x. Average trailing P/E is 26x in the Chemicals industry in Europe. Total loss to shareholders of 27% over the past three years.Valuation Update With 7 Day Price Move • Mar 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to лв40.00, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 25x in the Chemicals industry in Europe. Total loss to shareholders of 13% over the past three years.分析記事 • Mar 16Does Neochim AD's (BUL:NEOH) Share Price Gain of 71% Match Its Business Performance?Passive investing in index funds can generate returns that roughly match the overall market. But if you pick the right...Is New 90 Day High Low • Mar 13New 90-day high: лв31.80The company is up 33% from its price of лв24.00 on 11 December 2020. The Bulgarian market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period.Is New 90 Day High Low • Feb 24New 90-day high: лв31.00The company is up 30% from its price of лв23.80 on 19 November 2020. The Bulgarian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period.分析記事 • Feb 17Is There More Growth In Store For Neochim AD's (BUL:3NB) Returns On Capital?There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...Reported Earnings • Feb 02Full year 2020 earnings released: EPS лв6.01 (vs лв4.82 loss in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: лв226.5m (down 12% from FY 2019). Net income: лв15.5m (up лв28.0m from FY 2019). Profit margin: 6.9% (up from net loss in FY 2019). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 16% share price gain to лв29.20, the stock is trading at a trailing P/E ratio of 8.1x, up from the previous P/E ratio of 7x. This compares to an average P/E of 26x in the Chemicals industry in Europe. Total return to shareholders over the past three years is a loss of 44%.Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to лв29.20, the stock is trading at a trailing P/E ratio of 8.1x, up from the previous P/E ratio of 6.9x. This compares to an average P/E of 25x in the Chemicals industry in Europe. Total return to shareholders over the past three years is a loss of 45%.分析記事 • Jan 13Neochim AD (BUL:3NB) Has A Pretty Healthy Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...分析記事 • Dec 08Here's Why Neochim AD's (BUL:3NB) Statutory Earnings Are Arguably Too ConservativeBroadly speaking, profitable businesses are less risky than unprofitable ones. Having said that, sometimes statutory...収支内訳Neochim AD の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BUL:NEOH 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Mar 262191232031 Dec 25182029030 Sep 25164-427030 Jun 25156-725031 Mar 25159025031 Dec 24139-224030 Sep 24129-723030 Jun 24140-524031 Mar 24122-1622031 Dec 23150-1823030 Sep 23186-1524030 Jun 23195-1522031 Mar 23242-222031 Dec 223223623030 Sep 223305522030 Jun 223075121031 Mar 222815123031 Dec 211802421030 Sep 21130921030 Jun 21117722031 Mar 211061222031 Dec 20113724030 Sep 20112524030 Jun 20115524031 Mar 20122-826031 Dec 19131-628030 Sep 19143-430030 Jun 19140-930031 Mar 19131-1129031 Dec 18113-1027030 Sep 18109-926030 Jun 18115-426031 Mar 18116224031 Dec 17117623030 Sep 17116823030 Jun 17111723031 Mar 17108922031 Dec 161241222030 Sep 16119920030 Jun 161351320031 Mar 161501320031 Dec 15148520030 Sep 151530230質の高い収益: NEOHは 高品質の収益 を持っています。利益率の向上: NEOHの現在の純利益率 (5.6%)は、昨年(0.06%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: NEOHの収益は過去 5 年間で年間42%減少しました。成長の加速: NEOHの過去 1 年間の収益成長率 ( 13144.2% ) は、5 年間の平均 ( 年間-42%を上回っています。収益対業界: NEOHの過去 1 年間の収益成長率 ( 13144.2% ) はChemicals業界2.3%を上回りました。株主資本利益率高いROE: NEOHの 自己資本利益率 ( 13.4% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/07 00:08終値2026/08/07 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Neochim AD 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
分析記事 • Jun 05Neochim AD's (BUL:NEOH) Strong Earnings Are Of Good QualityEven though Neochim AD's ( BUL:NEOH ) recent earnings release was robust, the market didn't seem to notice. Our...
Reported Earnings • Jun 02First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: €81.5m (up 73% from 1Q 2025). Net income: €10.8m (up €11.7m from 1Q 2025). Profit margin: 13% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 03Full year 2025 earnings released: EPS: лв0.31 (vs лв1.50 loss in FY 2024)Full year 2025 results: EPS: лв0.31 (up from лв1.50 loss in FY 2024). Revenue: лв355.2m (up 31% from FY 2024). Net income: лв813.0k (up лв4.68m from FY 2024). Profit margin: 0.2% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year whereas the company’s share price has fallen by 21% per year.
Reported Earnings • Aug 30Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: лв77.8m (up 100% from 2Q 2023). Net income: лв8.51m (up лв22.3m from 2Q 2023). Profit margin: 11% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.
Reported Earnings • Jun 04First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: лв55.8m (down 48% from 1Q 2023). Net loss: лв5.77m (loss narrowed 41% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 03Full year 2023 earnings released: лв15.12 loss per share (vs лв27.09 profit in FY 2022)Full year 2023 results: лв15.12 loss per share (down from лв27.09 profit in FY 2022). Revenue: лв294.5m (down 53% from FY 2022). Net loss: лв39.1m (down 156% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
New Risk • Jul 03New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 12% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.8% average weekly change). Earnings have declined by 42% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€44.0m market cap, or US$50.2m).
New Risk • Jun 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bulgarian stocks, typically moving 7.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.7% average weekly change). Earnings have declined by 42% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€44.0m market cap, or US$50.2m).
Upcoming Dividend • Jun 25Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 29 June 2026. Payment date: 11 August 2026. The company last paid an ordinary dividend in July 2021. The average dividend yield among industry peers is 3.2%.
分析記事 • Jun 05Neochim AD's (BUL:NEOH) Strong Earnings Are Of Good QualityEven though Neochim AD's ( BUL:NEOH ) recent earnings release was robust, the market didn't seem to notice. Our...
Reported Earnings • Jun 02First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: €81.5m (up 73% from 1Q 2025). Net income: €10.8m (up €11.7m from 1Q 2025). Profit margin: 13% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bulgarian stocks, typically moving 9.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 44% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.9% average weekly change). Market cap is less than US$100m (€40.6m market cap, or US$46.9m).
分析記事 • Feb 12Returns On Capital Signal Tricky Times Ahead For Neochim AD (BUL:NEOH)Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €12.50, the stock trades at a trailing P/E ratio of 78.8x. Average trailing P/E is 19x in the Chemicals industry in Europe. Total loss to shareholders of 30% over the past three years.
Reported Earnings • Feb 03Full year 2025 earnings released: EPS: лв0.31 (vs лв1.50 loss in FY 2024)Full year 2025 results: EPS: лв0.31 (up from лв1.50 loss in FY 2024). Revenue: лв355.2m (up 31% from FY 2024). Net income: лв813.0k (up лв4.68m from FY 2024). Profit margin: 0.2% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year whereas the company’s share price has fallen by 21% per year.
分析記事 • Nov 29Why Investors Shouldn't Be Surprised By Neochim AD's (BUL:NEOH) Low P/SYou may think that with a price-to-sales (or "P/S") ratio of 0.2x Neochim AD ( BUL:NEOH ) is a stock worth checking...
分析記事 • Oct 19Improved Revenues Required Before Neochim AD (BUL:NEOH) Stock's 35% Jump Looks JustifiedNeochim AD ( BUL:NEOH ) shareholders have had their patience rewarded with a 35% share price jump in the last month...
Reported Earnings • Aug 30Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: лв77.8m (up 100% from 2Q 2023). Net income: лв8.51m (up лв22.3m from 2Q 2023). Profit margin: 11% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.
分析記事 • Jul 30Benign Growth For Neochim AD (BUL:NEOH) Underpins Its Share PriceNeochim AD's ( BUL:NEOH ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing investment...
Reported Earnings • Jun 04First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: лв55.8m (down 48% from 1Q 2023). Net loss: лв5.77m (loss narrowed 41% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
New Risk • Apr 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Bulgarian stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Market cap is less than US$100m (лв47.8m market cap, or US$26.2m).
Reported Earnings • Mar 03Full year 2023 earnings released: лв15.12 loss per share (vs лв27.09 profit in FY 2022)Full year 2023 results: лв15.12 loss per share (down from лв27.09 profit in FY 2022). Revenue: лв294.5m (down 53% from FY 2022). Net loss: лв39.1m (down 156% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
分析記事 • Jan 23Market Still Lacking Some Conviction On Neochim AD (BUL:NEOH)Neochim AD's ( BUL:NEOH ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing investment...
New Risk • Jan 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bulgarian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (7.5% average weekly change). Market cap is less than US$100m (лв73.2m market cap, or US$40.8m).
Reported Earnings • Nov 30Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: лв75.1m (down 19% from 3Q 2022). Net loss: лв201.0k (down 143% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 31Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: лв39.3m (down 70% from 2Q 2022). Net loss: лв13.8m (down 223% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
New Risk • Jul 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Bulgarian stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (6.0% average weekly change). Market cap is less than US$100m (лв81.5m market cap, or US$45.2m).
分析記事 • Jul 05Be Wary Of Neochim AD (BUL:NEOH) And Its Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...
Upcoming Dividend • Jun 27Upcoming dividend of лв5.00 per share at 19% yieldEligible shareholders must have bought the stock before 04 July 2023. Payment date: 17 August 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 19%. Within top quartile of Bulgarian dividend payers (7.3%). Higher than average of industry peers (4.2%).
Reported Earnings • Jun 02First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: лв108.9m (down 59% from 1Q 2022). Net loss: лв9.72m (down 115% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
お知らせ • May 31Neochim AD, Annual General Meeting, Jun 21, 2023Neochim AD, Annual General Meeting, Jun 21, 2023, at 12:00 E. Europe Standard Time.
Reported Earnings • Mar 01Full year 2022 earnings released: EPS: лв30.70 (vs лв18.04 in FY 2021)Full year 2022 results: EPS: лв30.70 (up from лв18.04 in FY 2021). Revenue: лв646.0m (up 83% from FY 2021). Net income: лв79.4m (up 70% from FY 2021). Profit margin: 12% (in line with FY 2021). Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 30Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: лв105.7m (up 124% from 3Q 2021). Net income: лв464.0k (up лв6.22m from 3Q 2021). Profit margin: 0.4% (up from net loss in 3Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 122% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 1 highly experienced director. No independent directors (7 non-independent directors). Deputy Chairperson Elena Shopova was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Upcoming Dividend • Jun 27Upcoming dividend of лв5.00 per shareEligible shareholders must have bought the stock before 04 July 2022. Payment date: 17 August 2022. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 9.1%. Within top quartile of Bulgarian dividend payers (7.0%). Higher than average of industry peers (3.8%).
Valuation Update With 7 Day Price Move • Apr 28Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to лв44.00, the stock trades at a trailing P/E ratio of 2.3x. Average trailing P/E is 14x in the Chemicals industry in Europe. Total returns to shareholders of 122% over the past three years.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). Deputy Chairperson Elena Shopova was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improved over the past weekAfter last week's 28% share price gain to лв50.50, the stock trades at a trailing P/E ratio of 2.6x. Average trailing P/E is 14x in the Chemicals industry in Europe. Total returns to shareholders of 107% over the past three years.
Valuation Update With 7 Day Price Move • Mar 14Investor sentiment improved over the past weekAfter last week's 18% share price gain to лв40.00, the stock trades at a trailing P/E ratio of 2.1x. Average trailing P/E is 14x in the Chemicals industry in Europe. Total returns to shareholders of 50% over the past three years.
Reported Earnings • Mar 04Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: лв19.50 (up from лв5.61 in FY 2020). Revenue: лв354.0m (up 60% from FY 2020). Net income: лв50.4m (up 248% from FY 2020). Profit margin: 14% (up from 6.5% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Feb 24Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to лв36.40, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 14x in the Chemicals industry in Europe. Total returns to shareholders of 28% over the past three years.
分析記事 • Feb 22The Returns At Neochim AD (BUL:NEOH) Aren't GrowingThere are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
Valuation Update With 7 Day Price Move • Jan 27Investor sentiment improved over the past weekAfter last week's 47% share price gain to лв33.00, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 16x in the Chemicals industry in Europe. Total returns to shareholders of 8.3% over the past three years.
分析記事 • Jan 25Neochim AD (BUL:NEOH) Seems To Use Debt Rather SparinglyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
お知らせ • Jan 13Daniel Rumenov Gargov acquired a 5.12% stake in Neochim AD (BUL:NEOH) from Agrofer International Establishment.Daniel Rumenov Gargov acquired a 5.12% stake in Neochim AD (BUL:NEOH) from Agrofer International Establishment on January 12, 2022. Post completion, Agrofer International Establishment hold 2.56% stake of Neochim AD. Daniel Rumenov Gargov completed the acquisition of a 5.12% stake in Neochim AD (BUL:NEOH) from Agrofer International Establishment on January 12, 2022.
Reported Earnings • Nov 30Third quarter 2021 earnings: Revenues in line with analyst expectationsThird quarter 2021 results: Revenue: лв48.5m (up 120% from 3Q 2020). Net loss: лв5.76m (loss narrowed 45% from 3Q 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
分析記事 • Nov 08Neochim AD's (BUL:NEOH) Shares Lagging The Market But So Is The BusinessWhen close to half the companies in Bulgaria have price-to-earnings ratios (or "P/E's") above 17x, you may consider...
分析記事 • Oct 05Capital Allocation Trends At Neochim AD (BUL:NEOH) Aren't IdealIgnoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...
Reported Earnings • Aug 29Second quarter 2021 earnings releasedThe company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: лв79.9m (up 40% from 2Q 2020). Net income: лв10.9m (down 48% from 2Q 2020). Profit margin: 14% (down from 37% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
分析記事 • Jun 07Neochim AD (BUL:NEOH) Has A Rock Solid Balance SheetSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Valuation Update With 7 Day Price Move • Apr 30Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to лв33.60, the stock trades at a trailing P/E ratio of 6x. Average trailing P/E is 26x in the Chemicals industry in Europe. Total loss to shareholders of 27% over the past three years.
Valuation Update With 7 Day Price Move • Mar 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to лв40.00, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 25x in the Chemicals industry in Europe. Total loss to shareholders of 13% over the past three years.
分析記事 • Mar 16Does Neochim AD's (BUL:NEOH) Share Price Gain of 71% Match Its Business Performance?Passive investing in index funds can generate returns that roughly match the overall market. But if you pick the right...
Is New 90 Day High Low • Mar 13New 90-day high: лв31.80The company is up 33% from its price of лв24.00 on 11 December 2020. The Bulgarian market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period.
Is New 90 Day High Low • Feb 24New 90-day high: лв31.00The company is up 30% from its price of лв23.80 on 19 November 2020. The Bulgarian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period.
分析記事 • Feb 17Is There More Growth In Store For Neochim AD's (BUL:3NB) Returns On Capital?There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...
Reported Earnings • Feb 02Full year 2020 earnings released: EPS лв6.01 (vs лв4.82 loss in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: лв226.5m (down 12% from FY 2019). Net income: лв15.5m (up лв28.0m from FY 2019). Profit margin: 6.9% (up from net loss in FY 2019). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 16% share price gain to лв29.20, the stock is trading at a trailing P/E ratio of 8.1x, up from the previous P/E ratio of 7x. This compares to an average P/E of 26x in the Chemicals industry in Europe. Total return to shareholders over the past three years is a loss of 44%.
Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to лв29.20, the stock is trading at a trailing P/E ratio of 8.1x, up from the previous P/E ratio of 6.9x. This compares to an average P/E of 25x in the Chemicals industry in Europe. Total return to shareholders over the past three years is a loss of 45%.
分析記事 • Jan 13Neochim AD (BUL:3NB) Has A Pretty Healthy Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 • Dec 08Here's Why Neochim AD's (BUL:3NB) Statutory Earnings Are Arguably Too ConservativeBroadly speaking, profitable businesses are less risky than unprofitable ones. Having said that, sometimes statutory...